IMR Press / RCM / Volume 23 / Issue 2 / DOI: 10.31083/j.rcm2302067
Open Access Original Research
Bibliometric analysis of the inflammatory mechanism in aortic disease
Show Less
1 Aortic and Vascular Surgery Center, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, 100037 Beijing, China
2 Shandong University, Qilu Hospital, 250012 Jinan, Shandong, China
*Correspondence: xiaogangsun2006@vip.sina.com (Xiaogang Sun)
Academic Editor: Giuseppe Santarpino
Rev. Cardiovasc. Med. 2022, 23(2), 67; https://doi.org/10.31083/j.rcm2302067
Submitted: 14 September 2021 | Revised: 7 October 2021 | Accepted: 14 October 2021 | Published: 17 February 2022
Copyright: © 2022 The Author(s). Published by IMR Press.
This is an open access article under the CC BY 4.0 license.
Abstract

Background: In view of the key role of inflammation in the pathogenesis of aortic disease, we visually analyzed the research hotspots of inflammatory mechanism in aortic disease in this work through the method of bibliometrics from the Web of Science (WOS) Core database over the past three decades. Methods: A visual bibliometric network of research articles on inflammatory mechanisms in aortic disease was obtained from VOSviewer and Citespace based on the WOS Core Collection. Results: A total of 1278 documents from January 1990 to February 2021 were selected for analysis. The United States and China had the highest percentage of articles, comprising 34.01% and 24.92% of articles worldwide, respectively. Harvard University has published the most articles in this field, followed by the University of Michigan and Huazhong University of Science and Technology. The top 3 research hotspots were atherosclerosis, oxidative stress, and macrophages. The journal with the most articles in this area was Arteriosclerosis Thrombosis and Vascular Biology, followed by Atherosclerosis and PLOS One. The research trend on inflammatory mechanisms in the aortic system has 5 distinct directions: (1) atherosclerosis, NF-κB, expression, smooth muscle cell, and oxidative stress; (2) coronary artery disease, C-reactive protein, risk factors, endothelial dysfunction, and aortic stenosis; (3) abdominal aortic aneurysm, matrix metalloproteinases, macrophage, and pathogenesis; (4) cholesterol, metabolism, low-density lipoprotein, gene expression, and a therosclerotic lesions; and (5) calcific aortic valve disease, interstitial cells, calcification, and stenosis. Conclusions: Inflammatory mechanism research has shown a tendency to rise gradually in the aortic field. Numerous studies have explored the role of inflammatory responses in aortic disease, which may increase the risk of endothelial dysfunction (aortic fibrosis and stiffness) and induce plaque formation. Among them, NFκB activation, nitric-oxide synthase expression, and oxidative stress are particularly essential.

Keywords
aortic disease
inflammation
inflammatory response markers
research hotspots
1. Introduction

Aortic disease, which mainly includes aortic aneurysm and aortic dissection, is a cardiovascular disease that seriously threatens health. According to the Institute for Health Metrics and Evaluation, the incidence of aortic dissection is approximately 4.7 cases per million annually, while that of aortic aneurysm is approximately 6 cases per 100,000 patient years [1]. With the modernization of lifestyles and high incidences of diseases such as hypertension, arteriosclerosis, and diabetes, the incidence of aortic disease is rising rapidly [2]. Therefore, its pathogenesis needs to be further explored. From a pathological perspective, this disease can be either hereditary or sporadic [3, 4]. Among them, aortic aneurysm is the dilatation of the whole aortic wall. Aortic dissection is the formation of a primary rupture in the aortic intima where the blood flow scours into the intima, which makes the aortic wall form true and false cavities and renders the weak outer wall of the blood vessel prone to rupture and bleeding [5]. Currently, few drugs are available to limit the progression of aortic disease, and only surgical treatment can be performed if the indications are met [6].

In recent years, different studies have showcased the existence and mechanisms of the inflammatory response and its relationship with aortic disease progression. Inflammatory cells infiltrate the media and outer wall of the aorta in cases of aneurysms and dissections, including lymphocytes, macrophages and mast cells, which normally participate in tissue damage responses and reconstruction [7]. At different stages of aortic stress, injury, repair, and remodeling, the cellular and extracellular components that make up the aortic wall adapt to the changes of the external environment [8]. However, in the inflammatory state, the imbalance of various components leads to biomechanical dysfunction and decreases wall compliance and mechanical strength, resulting in aortic aneurysm, dissection, and even rupture [9].

Although inflammatory mechanisms in aortic disease have only recently become popular research themes, no published bibliometric reports have analyzed the corresponding scientific data to summarize development processes and research hotspots and identify useful scientific trends in this field.

We used a bibliometric approach to identify and visualize scientific literature on the study of inflammatory mechanisms in aortic disease. This revealed popular research topics, key authors, scientific institutions, countries, and journals. We further aimed to capture and describe the specific diseases and signaling pathways that are most frequently investigated in studies of inflammatory mechanisms in aortic disease and to provide new insights for future studies.

2. Methods

Bibliometric analysis was performed based on the Core Collection of the Web of Science (WOS), which is considered the optimal data source for bibliometrics. The search formula was set to TS = (aortic disease) and TS = (inflammatory mechanism) from January 1, 1990 to February 21, 2021.

This yielded a total of 1278 records (Fig. 1). Only English original articles and reviews were considered in this study. Two authors, WLC and ZSY, separately selected and recorded the data. All disagreements were discussed until reaching a consensus. Related data were collected and recorded in Microsoft Excel (Microsoft, Redmond, WA, USA) for analysis.

Fig. 1.

Trends in the growth of the publications and numbers of cited articles worldwide from 1990 to 2021. There is an upward trend in the number of articles on the mechanisms of aortic inflammation from 1990 to 2021, with articles cited more frequently between 2015 and 2020, especially in 2020.

WOS-based literature analysis was used to summarize the general information of the distribution of publication years, journals, organizations, authors, and research fields, which was ranked using the Standard Competition Ranking method. Afterwards, the bibliometric analysis and network visualization including the top authors, keywords, research cooperation relationships, and co-citation network analysis of reference were performed with the VOSviewer version 1.6.16 software (Leiden University, Leiden, Netherlands) and Citespace version 5.7.R3 software (Drexel University, Philadelphia, PA, USA) [10, 11]. The “citation report” function from WOS was applied to assess citation rates and h-index. Each keyword has its own label and circle. Different colored circles represent different clusters, and the size of the circle is proportional to its frequency of occurrence [12].

3. Results
3.1 Chronological map of the literature

The number of research articles on aortic inflammatory mechanisms trended upward from 1990 to 2021 (Fig. 1). From 1990 to 2000, 2003 to 2007, 2012 to 2014, and 2017 to 2020, the number of published articles showed a steady increase. Meanwhile, there were slight declines in 2002, 2008, and 2015, and sharp rises in 2001, 2003, 2009, 2012, 2016, and 2017. The number peaked in 2020 and fell in 2021 due to incomplete trace time. Publications between 2015 and 2020 were cited with higher frequency, and the most cited articles were published in 2020 (Fig. 1).

3.2 National and regional distribution of the literature

Institutions from the United States and China published the most articles, accounting for 34% and 25% of the total number of articles, respectively. Their combined number comprised more than half of all articles, suggesting that these two countries had a high research interest in this field. As for actual citation index (ACI) values, the top three countries are the United States (53.3), Germany (52.6), and Japan (51.2), indicating that they have been working on this field for longer than other countries and have produced more advanced and mature results (Table 1).

Table 1.Top 10 productive countries in regard to the research on inflammatory mechanism in aortic disease.
Rank Country Quantity Percentage ACI H-index Total link strength
1 USA 434 34 53.3 85 536
2 China 320 25 15.9 36 353
3 Japan 94 7.4 51.2 30 130
4 England 72 5.6 39.6 32 109
5 Germany 71 5.6 52.6 32 87
6 France 61 4.8 35.8 22 88
7 Italy 61 4.8 29.5 22 107
8 Spain 46 3.6 40.8 18 51
9 Canada 43 3.4 31.9 21 32
10 South Korea 42 3.3 24.5 16 39
ACI, average citations per item.

There are four distinct clusters of regional close cooperation (Fig. 2). The United States and China most frequently collaborated with the United Kingdom, Japan, Canada, and Italy; Germany and England with Spain, Switzerland, and India; Japan with South Korea; and Italy with Austria.

Fig. 2.

Cooperation map of countries of inflammatory mechanism in aortic disease. Different colors represent different countries that work closely together, the size of the circle is proportional to the total number of articles from that country, and the distance between two countries is inversely proportional to the number of articles from those two countries. Among them, four distinct groups of regions work closely together.

As shown in Fig. 3, the average number of citations per publication per country over the entire period of analysis (1990–2021) was approximately 26, with the most cited countries being the US 91 (430), China (316), and Japan (92).

Fig. 3.

World map depicting the average number of citations per paper related to aortic inflammation published from 1990–2021. The background color of the country is positively correlated with the average citation rate, and countries in the same color may have co-authorship of articles. Of these, the most cited country is the United States.

3.3 Distributions of authors and institutions

Xianzhong Meng, David Fullerton and Lihua Ao from the University of Colorado ranked among the top three authors in terms of the number of publications. Among the top 10 authors published, nine are from the United States, including four from the University of Colorado and three from Temple University. The top three authors in citation frequency were Elena Aikawa from Brigham and Women’s Hospital of Harvard Medical School, Hong Wang from Temple University, and Xianzhong Meng from the University of Colorado (Table 2).

Table 2.Top 10 authors in the studies of inflammatory mechanism in aortic disease.
Rank Author Country Institution Total publications Citations H-index Total link strength
1 Xianzhong Meng USA University of Colorado System 12 251 8 157
2 David Fullerton USA University of Colorado Denver 10 243 7 148
3 Lihua Ao USA University of Colorado System 7 196 5 128
4 Dingli Xu China Southern Medical University 5 91 4 91
5 Rui Song USA Loma Linda University 6 123 6 90
6 Qingchun Zeng USA & China University of Colorado Denver & Southern Medical University 5 99 5 83
7 Elena Aikawa USA Harvard university & Brigham and Women’s Hospital 7 685 7 31
8 Hong Wang USA Temple University 8 266 10 16
9 Xiaohua Jiang USA Temple University 5 194 7 14
10 Xinyuan Li USA Temple University 5 160 7 14

Fig. 4 shows clusters of authors that collaborated. For example, Masanori Aikawa collaborated closely with Norbert Gerdes, and Haipeng Guo collaborated closely with Yingjie Chen and Yuan Li.

Fig. 4.

Cooperation map of authors in the studies of inflammatory mechanism in aortic disease. Different colors represent different authors who work closely together, the size of the circle is proportional to the total number of articles by that author, and the distance between the two authors is inversely proportional to the degree of cooperation between them.

The institution with the largest number of research papers published in this field is Harvard University with 32 papers, followed by Huazhong University with 22 papers, and Shandong University with 19 papers. The institution which had the top ACI value in this field is the University of California in Los Angeles (120.73), followed by Harvard University (85.38) and Brigham and Women’s Hospital 105 (60) (Table 3).

Table 3.Top 10 institutions in the studies of inflammatory mechanism in aortic disease.
Institution Country Quantity ACI STC Total link strength
1 HARVARD UNIV USA 32 85.38 2732 15
2 HUAZHONG UNIV SCI TECHNOL China 22 19.59 431 13
3 SHANDONG UNIV China 19 14.42 274 12
4 CHINA MED UNIV China 18 11.61 209 12
5 UNIV MICHIGAN USA 17 46.59 792 10
6 CAPITAL MED UNIV China 16 21.56 345 8
7 KAROLINSKA INST Sweden 16 47.88 766 8
8 SOUTHERN MED UNIV China 16 9.94 159 6
9 BRIGHAM WOMENS HOSP USA 15 60 900 6
10 UNIV CALIF LOS ANGELES USA 15 120.73 1811 5
ACI, average citations per item; STC, sum of the times cited.

The different colors in Fig. 5 show clusters of intimate relationships between different research institutions. For example, Harvard University collaborated closely with the University of Michigan, Huazhong University of Science, Cornell University, and Tokyo Medical and Dental University, and China Medical University collaborated closely with Chang Gung University and Yale University.

Fig. 5.

Cooperation map of institutions in the studies of inflammatory mechanism in aortic disease. Different colors represent different institutions that cooperate closely, the size of the circle is proportional to the total number of articles in that institution, and the distance between two institutions is inversely proportional to the degree of cooperation between them.

3.4 Disciplinary distribution of the literature

The top three disciplines with the most published articles were cardiac cardiovascular systems (20.6%), peripheral vascular disease (19.1%), and biochemistry/molecular biology (13.9%). Other disciplines represented in the literature included pharmacology/pharmacy (13.3%), cell biology (10.3%), experimental medicine research (8.5%), hematology (6.6%), multidisciplinary sciences (5.6%), immunology (5.1%), surgery (5%), and other disciplines. This indicated that the research performed in this field was broad and that the research methods were diverse (Table 4).

Table 4.Top 10 subject categories in the studies of inflammatory mechanism in aortic disease.
Rank Quantity WOS categories Percentage
1 261 CARDIAC CARDIOVASCULAR SYSTEMS 20.6
2 241 PERIPHERAL VASCULAR DISEASE 19.1
3 176 BIOCHEMISTRY MOLECULAR BIOLOGY 13.9
4 168 PHARMACOLOGY PHARMACY 13.3
5 130 CELL BIOLOGY 10.3
6 108 MEDICINE RESEARCH EXPERIMENTAL 8.5
7 84 HEMATOLOGY 6.6
8 71 MULTIDISCIPLINARY SCIENCES 5.6
9 65 IMMUNOLOGY 5.1
10 63 SURGERY 5

The journals with the highest number of articles in this field were Arteriosclerosis Thrombosis and Vascular Biology and Atherosclerosis (44 each), followed by PLOS One (41), Circulation (28), Biochemical and Biophysical Research Communications (23), and Circulation Research (22). The magazine with the highest ACI value was Circulation (143.6), followed by Cardiovascular Research (76.1), Arteriosclerosis Thrombosis and Vascular Biology (69.2), Circulation Research (69.1), Atherosclerosis (40), PLOS One (21.7), and Vascular Pharmacology (21.3) (Table 5).

Table 5.Top 10 journals in the studies of inflammatory mechanism in aortic disease.
Rank Journal Quantity ACI
1 ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY 44 69.2
2 ATHEROSCLEROSIS 44 40
3 PLOS ONE 41 21.7
4 CIRCULATION 28 143.6
5 BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 23 19.7
6 CIRCULATION RESEARCH 22 69.1
7 CARDIOVASCULAR RESEARCH 19 76.1
8 INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 15 10.1
9 SCIENTIFIC REPORTS 15 16
10 VASCULAR PHARMACOLOGY 15 21.3
ACI, average citations per item.
3.5 Analysis of highly cited literature

As shown in Table 6, the most cited article was “Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-kappa B signaling through a cAMP-dependent pathway,” in which Ouchi et al. [13] discussed the mechanism of modulation of endothelial function by adiponectin.

Table 6.Top 10 co-cited articles, cited authors, and cited references in the studies of inflammatory mechanism in aortic disease.
Rank Article title Journal Type Authors Y C IN CN
1 Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-kappa B signaling through a cAMP-dependent pathway CIRCULATION Original Article Noriyuki et al. 2000 1354 2 1
2 The role of oxidized lipoproteins in atherogenesis FREE RADICAL BIOLOGY AND MEDICINE Review Judith et al. 1996 1140 4 1
3 Magnetic resonance imaging of atherosclerotic plaque with ultrasmall superparamagnetic particles of iron oxide in hyperlipidemic rabbits CIRCULATION Original Article Stefan et al. 2001 456 4 3
4 Inflammation and cellular immune responses in abdominal aortic aneurysms ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY Review Koichi et al. 2006 401 2 1
5 Antagonistic crosstalk between NF-kappa B and SIRT1 in the regulation of inflammation and metabolic disorders CELLULAR SIGNALLING Review Anu et al. 2013 397 4 1
6 Host bone-marrow cells are a source of donor intimal smooth-muscle-like cells in murine aortic transplant arteriopathy NATURE MEDICINE Original Article Koichi et al. 2001 392 1 1
7 Modified low-density-lipoprotein and its constituents augment cytokine-activated vascular cell-adhesion molecule-1 gene-expression in human vascular endothelial JOURNAL OF CLINICAL INVESTIGATION Comparative Study B V Khan et al. 1995 385 2 1
8 Induction of I kappa B alpha expression as a mechanism contributing to the anti-inflammatory activities of peroxisome proliferator-activated receptor-alpha activators JOURNAL OF BIOLOGICAL CHEMISTRY Original Article Philippe et al. 2000 362 2 1
9 Induction of inflammation in vascular endothelial cells by metal oxide nanoparticles: Effect of particle composition ENVIRONMENTAL HEALTH PERSPECTIVES Original Article Andrea et al. 2007 354 2 1
10 Update on spondyloarthropathies ANNALS OF INTERNAL MEDICINE Review Muhammad et al. 2002 324 1 1
Y, year; C, citations; IN, institute number; CN, country number.

The second most cited article was “The role of oxidized lipoproteins in atherogenesis”. In this article, Berliner and Heinecke reviewed the understanding as of 1996 of the mechanisms of low-density lipoprotein oxidation and the potential role of oxidized lipoproteins in atherosclerosis [14].

The third most cited article was “Magnetic resonance imaging of atherosclerotic plaque with ultrasmall superparamagnetic particles of iron oxide in hyperlipidemic rabbits”. In this article, Ruehm et al. [15] confirmed that ultrasmall superparamagnetic particles of iron oxide are phagocytosed by macrophages in atherosclerotic plaques of the aortic wall of hyperlipidemic rabbits in a quantity sufficient to cause susceptibility effects detectable by magnetic resonance imaging.

These papers have presented a crucial theoretical basis as well as clinical evidence for research in this area. Four of the most highly cited articles were reviews, while seven were original articles. The most highly cited articles were published from 2000 to 2007.

This period could be considered to represent the leaping development stage of this field. During this period, there were eight papers with at least two institutions but only one article with more than one country.

3.6 Hotspots and future directions
3.6.1 Analysis of research hotspots

Keywords represent the intrinsic content of the paper and thus are used to find the evolution of related research frontiers [16]. As illustrated in Table 7, besides “inflammation” and “atherosclerosis”, the keywords that appeared most frequently were “oxidative stress” (71), “macrophage” (57), “abdominal aortic aneurysm” (43), “cardiovascular disease” (33), “endothelial cells” (34), and “endothelial dysfunction” (30).

Table 7.Top 10 keywords in the studies of inflammatory mechanism in aortic disease.
Rank Keyword Occurrence Total link strength
1 Inflammation 306 457
2 Atherosclerosis 330 380
3 Oxidative stress 71 118
4 Macrophage 57 104
5 Abdominal aortic aneurysm 43 58
6 Cardiovascular disease 33 50
7 Endothelial cells 34 50
8 Endothelial dysfunction 30 45
9 Calcification 27 44
10 NF-kappa B 31 41

Fig. 6 presents the keywords co-occurrence network map; the thicker the connection between the nodes is, the more frequently the two keywords appear together. The keywords formed 5 clusters, representing five major research directions in the field.

Fig. 6.

Map of keyword clustering in the studies of inflammatory mechanism in aortic disease. The size of the circles is proportional to the number of occurrences of the keywords. The proximity of the circles indicates the frequency of co-occurrence between the two corresponding terms, and the closer they are, the higher the degree of cooperation between them.

3.6.2 Red cluster (Part 1)

Papers with the keyword “atherosclerosis” researched the pyrin domain 3 inflammasomes [17], toll- like receptor 4 [18], high low-density lipoprotein (LDL) cholesterol [19], and high lipoprotein(a) [20] to elucidate the inflammatory mechanism in aortic diseases. Papers with the keyword “NFκB” studied the TLR3-TRIF-NFκB pathway [21] regulated by polyinosinic-polycytidylic acid [22] in aortic valve interstitial cells and its activity in both valve endothelial and interstitial cells in calcific aortic valve disease models [23]. Papers with the keyword “smooth muscle cells” discussed rat aortic [24] and vascular smooth muscle cells [25] that served as the cell model in aortic disease experiments. Papers with the keyword “oxidative stress” investigated its contribution in abdominal aortic aneurysm (AAA) [26] and the effect of mediator myeloperoxidase (MPO) [27] in thoracic aortic aneurysm (TAA) [28], which showed that the Janus kinase/STAT pathway inhibited by S1 peptide [29] slowed the progression of AAA. Furthermore, commonly prescribed medications such as methotrexate and doxycycline alleviated and prevented cardiovascular diseases [30].

3.6.3 Purple cluster (Part 2)

Papers with the keyword “coronary artery diseases” (CAD) researched regulators in patients with Kawasaki disease [31] and rheumatoid arthritis [32]. In addition, they studied the use of 18F- fluorodeoxyglucose positron emission tomography imaging [33] for identifying CAD and biomarker proprotein convertase subtilisin/kexin type-9 [34] for predicting CAD. Papers with the keyword “C- reactive protein” (CRP) discussed a positive correlation with arterial stiffness [35] and acute aortic syndromes [36]. Risk factors included age, gender, obesity, smoking, hyperlipidemia, hypertension, and type II diabetes mellitus in aortic diseases [37]. Papers with the keyword “endothelial dysfunction” evaluated berberine for treatment [38], μ-calpain isoform [39], and microparticles [40] as part of the signaling pathway.

3.6.4 Yellow cluster (Part 3)

Papers with the keyword “abdominal aortic aneurysm” researched the mechanistic target of the rapamycin (mTOR) pathway [41], roles of interleukin (IL)-1β [42] and tumor necrosis factor α (TNFα) [43], and the use of spermidine [44] for treatment. Papers with the keyword “matrix metalloproteinases” (MMP) studied the mechanisms of aortic diseases induced by MPO-derived oxidative species [45] and inhibited by doxycycline [46] and hydroxymethylglutaryl-coenzyme A reductase [47]. Papers with the keyword “macrophages” discussed the major role of TNFα inhibition [43] in macrophages in AAA. Also, IL-3 [48] activated macrophages secreted MMP12 [49] in TAA and dissection (TAAD) through mitogen-activated protein kinases pathways [50]. Papers with the keyword “pathogenesis” investigated mechanisms of AAA, TAA, and TAAD [51].

3.6.5 Blue cluster (Part 4)

Papers with the keyword “cholesterol” researched its accumulation leading to atherosclerosis [52]. Papers with the keywords “cholesterol” and “low-density lipoprotein” both investigated the role of LDL cholesterol [53] in diseases related to bicuspid aortic valve [54] and proprotein convertase subtilisin/kexin type 9 [55], which decreased the removal of LDL cholesterol leading to a high risk of atherosclerosis. Papers with the keyword “metabolism” discussed arachidonic acid metabolism [56], nicotinamide adenine dinucleotide metabolism [57], lipid metabolism [58], and secreted phospholipase A2-driven phospholipid metabolism [59]. Papers with the keyword “gene expression” investigated gene expression profiling [60] and approaches for detecting inflammation factors [61] and extracellular matrix (ECM) proteins including MMP [62].

3.6.6 Green cluster (Part 5)

Papers with the keyword “calcific aortic valve diseases” (CAVD) researched its markers, treatment targets such as cadherin-11 [63], and surgical aortic valve replacement [64]. Papers with the keyword “interstitial cells” studied aortic valve interstitial cells (AVICs) [65], interstitial cell phenotypes [66], and their role in CAVD [67]. Papers with the keyword “calcification” discussed apatite [68], non- canonical Wnt signaling [69], microRNA-214 via MyD88/NF-κB signaling pathway in AVICs [70], and iron that could be taken up by VIC [71] and subsequently contribute to proliferation [72]. Papers with the keyword “stenosis” investigated aortic stenosis in terms of early diagnosis [73], risk factors [74], and association with CAVD [75].

3.7 Integrated evolutionary path of the literature

As shown in Fig. 7, the year corresponding to each keyword is the first year in which it appears in the analyzed dataset. The shift between nodes can uncover the development of inflammatory mechanisms in aortic research hotspots. From 2010 to 2012, inflammatory mechanism research began to focus on NFκB [76], oxidative stress [77], apoptosis [78], endothelial cells [79], and atherosclerosis [80]. From 2013 to 2015, diabetes mellitus [81], knockout mice [82], LDL cholesterol [83], and macrophages [84] received increased attention. Furthermore, MMPs [85], aortic aneurysm [86], hypertension [87], and dysfunction [88] became the new focus from 2016 to 2018. From 2019 to 2021, the field turned to research on chronic kidney disease [89], oxidative stress, proliferation [90], monocytes [91], and protein [92].

Fig. 7.

Evolutionary path in the studies of inflammatory mechanism in aortic disease. The keywords were clustered and arranged by the year of first appearance to form a timeline chart. Variations between nodes can reveal the evolution of inflammatory response in the aortic research hotspot.

3.8 Recognition of research frontiers in the literature

In Table 8, a blue line is used to mark the timeline. The red segment on top of the blue line represents burst detections by showing the start year, end year, and duration of the burst. We intended to find keywords with research significance to reflect the evolutionary trend of this field. “Dysfunction” showed the strongest burst strength, followed by “gene expression” [93], “low-density lipoprotein” [83] and “insulin resistance” [94]. The terms “nitric oxide” [95] and “insulin resistance” first appeared recently but lasted for a short duration. The burst times of “in vivo” [96] and “gene expression” were consistent. “Stenosis”, “proliferation” and “pathogenesis” [97] are the current research frontiers in this field and are currently within the burst period.

Table 8.Top 20 keywords with the strongest citation bursts in the studies of inflammatory mechanism in aortic disease.
4. Discussion

This work conducted a bibliometric analysis of literature published from 1990 to 2021 on inflammatory mechanisms in aortic disease using CiteSpace (Drexel University, Philadelphia, PA, USA) and VOSviewer (Leiden University, Leiden, Netherlands) software. The analysis focused on the spatial and temporal allocation, author contribution, core literature, heated topics, and research frontier analysis. Using keyword co-occurrence analysis, we were able to identify heated research topics from each period and unveil the evolutionary path of this research area. Afterwards, we identified the current research frontiers of research of inflammatory mechanisms in aortic disease. The main conclusions are as follows.

4.1 Research of inflammatory mechanisms in aortic disease shows an upward zigzag trend

In recent years, people have given more attention to the role of the inflammatory response in the occurrence and development of aortic disease. Aortic wall media degeneration is an important cause of aortic disease formation while the inflammatory response participates in the process of aortic wall remodeling [98]. Some inflammatory cells and factors, such as macrophages, mast cells, and CRP, have been found to change with time in the process of dissection and prognosis, suggesting the possible value of the inflammatory response in the diagnosis and prognosis of aortic disease [99]. Choke et al. [100] found that inflammation regulates endothelial cells to induce intimal neovascularization, which accelerates the degradation of media ECM and the migration of aortic endothelial cells, resulting in decreased aortic strength. Inflammation is closely related to the clinical outcome of aortic disease. However, the clinical application of aortic disease treatment through the intervention of inflammation is still in its infancy, and related research and practice still needs to be continuously promoted [101].

4.2 Studies on the inflammatory response in the aorta first began in the United States and China, followed by increasing attention in Japan and the United Kingdom

Research in the United States and China started earlier and has had more time to develop. For example, Harvard University, the University of California in Los Angeles, and Huazhong University of Science and Technology have published a large quantity of high-quality studies. Harvard University mainly studied Th1/Th2 cytokine balance in modulating matrix remodeling [102] and pathological smooth muscle cells derivation in graft arterial disease [103]. The University of California in Los Angeles explored the effect of NFκB signaling on inflammatory gene expression [104] and oxidized LDL cholesterol in aortic stenosis [14]. Huazhong University of Science and Technology explored the effect of drugs on inhibiting oxidative stress and inflammation via the NFκB signaling pathway [105], such as metformin [106], Tanshinone IIA [107], and anthraquinone emodin [108].

4.3 Inflammatory response markers are research hotspot in this field

Inflammatory markers refer to indices that can indicate the existence and progression of inflammatory reactions in clinical diagnosis. After the occurrence of aortic disease, the injury site induces local and systemic inflammatory responses by releasing chemokines, and the changes of related inflammatory markers can also indicate the process of occurrence and development of aortic disease [109]. It is essential to determine diagnostic and predictive factors with high sensitivity and specificity by studying biomarkers related to peripheral circulatory inflammation.

In the process of AAA, many inflammatory cells, including macrophages, mast cells, and neutrophils, infiltrate from the adventitia of the aorta to the intima layer by layer, causing a series of inflammatory reactions. Inflammatory cells and their secreted cytokines, such as IL-1β, IL-6, and IL- 33, stimulate vascular smooth muscle cells to secrete MMPs, which are directly related to the formation and progression of AAA [110]. Through the degradation of elastin and collagen, these enzymes lead to vascular smooth muscle cell apoptosis and ECM degradation, thus destroying the stability of the aortic wall. Therefore, inflammation has a profound effect on the occurrence and progression of AAA.

IL-6 is a multifunctional circulating cytokine and is related to inflammation, host resistance, and tissue injury. IL-6 is secreted by a variety of different cells, including activated macrophages and lymphocytes, and binds to high-affinity receptor complexes. As a classical inflammatory factor, IL-6 plays an important role in the development and progression of aortic disease and is gradually becoming a reliable biomarker for its diagnosis and the assessment of therapeutic effects and prognosis of patients with aortic disease. Wen et al. [99] found that serum IL-6 levels in patients with aortic disease increased in the acute phase and gradually decreased to normal levels in the chronic phase. Ju et al. [111] discovered that aortic disease is triggered by the IL-6 signaling pathway and transcription-3 activator through the Th17 lymphocyte-IL-17 axis. Tieu et al. [112] found that IL-6 is predominantly located in the tunica adventitia, where monocytes are recruited and activated, leading to promotion of monocyte chemoattractant protein-1 secretion, vascular inflammation, ECM degradation, and aortic instability. It has been recently reported that reducing IL-6 levels by some therapeutic interventions (e.g., antithrombin, dexmedetomidine, ulinastatin) can effectively delay or even reverse progression of aortic disease [113].

CRP is a cyclic pentamer protein found in plasma, which originates from the liver and increases after IL-6 secretion from macrophages and T cells. CRP binds to lysophosphatidylcholine expressed on the surface of dead or dying cells to activate the complement system through C1q. As one of the major and most sensitive markers of non-specific acute phase inflammation in humans, CRP is widely used to predict adverse events in cardiovascular disease. Sbarouni et al. [114] found that CRP values were more than five times higher in patients with acute aortic disease than in healthy people. Sakakura et al. [115] found that the peak value of CRP in patients with aortic disease during the perioperative period was strongly associated with medium- and long-term adverse events. CRP has been demonstrated to promote expression of MMP-1, an enzyme that plays an important role in plaque fragility and is primarily responsible for cleavage of type I and type III fibrillar collagen, which is a key matrix component of atherosclerotic plaques. CRP increases MMP-1 expression through the extracellular signal-regulated kinase (ERK) pathway. Following elevated CRP levels, the phosphorylation of ERK1/2 reaches a maximum and then decreases. In addition, it has been demonstrated that CRP promotes the expression of AT1-R, a receptor that mediates the proinflammatory effects of angiotensin II, thus promoting the migration and proliferation of vascular smooth muscle in vitro and in vivo, making it one of the most important bioactive factors involved in the development and progression of atherosclerosis.

TNFα, a 17-kDa protein consisting of 157 amino acids, is mainly produced by activated macrophages, T lymphocytes, and natural killer cells. TNFα plays multiple roles in inducing inflammation and is involved in the regulation of cellular transport and activation, pathogen resistance, and immune inflammatory responses. Wen et al. [116] reported that TNFα levels were higher in patients with acute aortic disease than in healthy people. Enhancing vascular TNFα by SM22-TNFα transgenes in mice upregulates the aortic Msx2-Wnt3a/Wnt7a axis, leading to increased aortic calcium accumulation. Therapy with infliximab, a TNFα-neutralizing antibody, abolishes aortic BMP-2-Msx2- Wnt3a and Wnt7a signaling and significantly alleviates aortic calcium accumulation. In addition, it has also been shown that TNFα can upregulate adhesion molecule expression, leading to formation of fatty streaks and the initiation of atherosclerosis, and is involved in inflammation that leads to plaque rupture.

MMPs are a family of zinc-dependent endopeptidases that target proteins of the ECM. Alterations in specific MMPs could influence arterial remodeling and lead to various pathological disorders such as hypertension, preeclampsia, atherosclerosis, aneurysm formation, excessive venous dilation, and lower extremity venous disease. Accumulating evidence suggests that increased expression and activity of MMPs in the aortic wall are associated with alterations in histology [117]. In particular, the imbalance between MMPs and tissue inhibitors of MMPs (TIMPs) predisposes ECM degeneration, which induces aortic dilatation and dissection. Factors affecting the regulation of MMPs (e.g., cytokines, plasma systems) seem likely to play a synergistic role in AAA development. It has also been confirmed that the main reason for increased genetic susceptibility to AAA is variation in MMPs, TIMPs, and their mediating genes. Guo et al. [118] found that inhibition of MMP-9 expression with IL-1β antibodies effectively mitigated the progression of aortic disease.

5. Conclusions

The present study is the first bibliometric analysis of research publications on inflammatory mechanisms in aortic disease worldwide. Using information visualization technology, we have assessed the progression and evolution of research in this field, research hot spots, and future study directions into research on inflammatory responses in aortic disease using literature from the past 30 years. The inflammatory response has a crucial role in both research progression and broad application prospects in cardiovascular diseases. This research area is characterized as a multinational cooperation with multidisciplinary intersections, and inflammatory response markers and therapeutic anti- inflammation options will be the focus of future studies.

Based on our discussion and analysis above, we are currently considering several further analyses: (1) more in-depth analysis of specific inflammatory response pathways in specific aortic diseases, such as the TLR3-TRIF-NFκB pathway in aortic dissection; (2) comparison of research output trends in other disease areas where a combination of bibliometric and medical skills is useful; and (3) periodically repeating such analyses to observe temporal trends in research results, improve the accuracy of research hotspots, and encourage close collaboration among relevant countries and scholars to ultimately facilitate the diagnosis, treatment, and prevention of aortic disease.

Author contributions

LCW and XGS—conception and design; YXL and YFL—administrative support; LCW and SYZ—provision of study materials or patients; LCW—collection and assembly of data; LCW—data analysis and interpretation. All authors write and approved the final manuscript.

Ethics approval and consent to participate

The authors are accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. The study was conducted in accordance with the Declaration of Helsinki (as revised in 2013). This study protocol was approved by the Institutional Ethics Committee of Fuwai Hospital (No. 2018-1069).

Acknowledgment

We would like to express our gratitude to all those who helped us during the writing of this manuscript. Thanks to all the peer reviewers for their opinions and suggestions.

Funding

This study was supported by Beijing Municipal Science and Technology Commission, China, Major Special Project #Z181100001718197.

Conflict of interest

The authors declare no conflict of interest.

References
[1]
Pacini D, Di Marco L, Fortuna D, Belotti LMB, Gabbieri D, Zussa C, et al. Acute aortic dissection: epidemiology and outcomes. International Journal of Cardiology. 2014; 167: 2806–2812.
[2]
Bossone E, Eagle KA. Epidemiology and management of aortic disease: aortic aneurysms and acute aortic syndromes. Nature Reviews Cardiology. 2021; 18: 331–348.
[3]
Einarson TR, Acs A, Ludwig C, Panton UH. Prevalence of cardiovascular disease in type 2 diabetes: a systematic literature review of scientific evidence from across the world in 2007–2017. Cardiovascular Diabetology. 2018; 17: 83.
[4]
Zhu K, Wang Y, Zhu J, Zhou Q, Wang N. National prevalence of coronary heart disease and its relationship with human development index: a systematic review. European Journal of Preventive Cardiology. 2016; 23: 530–543.
[5]
Golledge J. Abdominal aortic aneurysm: update on pathogenesis and medical treatments. Nature Reviews Cardiology. 2019; 16: 225–242.
[6]
Marquis-Gravel G, Redfors B, Leon MB, Généreux P. Medical Treatment of Aortic Stenosis. Circulation. 2017; 134: 1766–1784.
[7]
Marvisi C, Buttini E A, Vaglio A. Aortitis and periaortitis: the puzzling spectrum of inflammatory aortic diseases. La Presse Médicale. 2020; 49: 104018.
[8]
Watanabe R, Berry GJ, Liang DH, Goronzy JJ, Weyand CM. Cellular Signaling Pathways in Medium and Large Vessel Vasculitis. Frontiers in Immunology. 2020; 11: 587089.
[9]
Akhavanpoor M, Wangler S, Gleissner CA, Korosoglou G, Katus HA, Erbel C. Adventitial inflammation and its interaction with intimal atherosclerotic lesions. Frontiers in Physiology. 2014; 5: 296.
[10]
van Eck NJ, Waltman L. Software survey: VOSviewer, a computer program for bibliometric mapping. Scientometrics. 2010; 84: 523–538.
[11]
Chen C. CiteSpace II: Detecting and visualizing emerging trends and transient patterns in scientific literature. Journal of the American Society for Information Science and Technology. 2006; 57: 359–377.
[12]
Zou X, Yue WL, Vu HL. Visualization and analysis of mapping knowledge domain of road safety studies. Accident Analysis and Prevention. 2018; 118: 131–145.
[13]
Ouchi N, Kihara S, Arita Y, Okamoto Y, Maeda K, Kuriyama H, et al. Adiponectin, an Adipocyte-Derived Plasma Protein, Inhibits Endothelial NF-kB Signaling Through a cAMP-Dependent Pathway. Circulation. 2020; 12: 1296–1301.
[14]
Berliner JA, Heinecke JW. The role of oxidized lipoproteins in atherogenesis. Free Radical Biology and Medicine. 1996; 20: 707–727.
[15]
Ruehm SG, Corot C, Vogt P, Kolb S, Debatin JF. Magnetic resonance imaging of atherosclerotic plaque with ultrasmall superparamagnetic particles of iron oxide in hyperlipidemic rabbits. Circulation. 2001; 103: 415–422.
[16]
Chen C. Searching for intellectual turning points: progressive knowledge domain visualization. Proceedings of the National Academy of Sciences of the United States of America. 2004; 101: 5303–5310.
[17]
Grebe A, Hoss F, Latz E. NLRP3 Inflammasome and the IL-1 Pathway in Atherosclerosis. Circulation Research. 2018; 122: 1722–1740.
[18]
Balistreri CR, Ruvolo G, Lio D, Madonna R. Toll-like receptor-4 signaling pathway in aorta aging and diseases: “its double nature”. Journal of Molecular and Cellular Cardiology. 2017; 110: 38–53.
[19]
Després JP, Lemieux I, Dagenais GR, Cantin B, Lamarche B. HDL-cholesterol as a marker of coronary heart disease risk: the Que´bec cardiovascular study. Atherosclerosis. 2000; 153: 263–272.
[20]
Lütjohann D, Stellaard F, Mulder MT, Sijbrands EJG, Weingärtner O. The emerging concept of “individualized cholesterol-lowering therapy”: A change in paradigm. Pharmacology and Therapeutics. 2019; 199: 111–116.
[21]
Zhan Q, Song R, Li F, Ao L, Zeng Q, Xu D, et al. Double-stranded RNA upregulates the expression of inflammatory mediators in human aortic valve cells through the TLR3-TRIF-noncanonical NF-κB pathway. American Journal of Physiology - Cell Physiology. 2017; 312: C407–C417.
[22]
Mori D, Koide N, Tsolmongyn B, Nagata H, Sano T, Nonami T, et al. Poly I:C enhances production of nitric oxide in response to interferon-γ via upregulation of interferon regulatory factor 7 in vascular endothelial cells. Microvascular Research. 2015; 98: 68–73.
[23]
García-Rodríguez C, Parra-Izquierdo I, Castaños-Mollor I, López J, San Román JA, Sánchez Crespo M. Toll-Like Receptors, Inflammation, and Calcific Aortic Valve Disease. Frontiers in Physiology. 2018; 9: 201.
[24]
Zhou B, Qiu Y, Wu N, Chen AD, Zhou H, Chen Q, et al. FNDC5 Attenuates Oxidative Stress and NLRP3 Inflammasome Activation in Vascular Smooth Muscle Cells via Activating the AMPK-SIRT1 Signal Pathway. Oxidative Medicine and Cellular Longevity. 2020; 2020: 6384803.
[25]
Bonnet AL, Chaussain C, Broutin I, Rochefort GY, Schrewe H, Gaucher C. From Vascular Smooth Muscle Cells to Folliculogenesis: what about Vasorin? Frontiers in Medicine. 2018; 5: 335.
[26]
Emeto TI, Moxon JV, Au M, Golledge J. Oxidative stress and abdominal aortic aneurysm: potential treatment targets. Clinical Science. 2016; 130: 301–315.
[27]
Ndrepepa G. Myeloperoxidase - A bridge linking inflammation and oxidative stress with cardiovascular disease. Clinica Chimica Acta. 2019; 493: 36–51.
[28]
Nogi M, Satoh K, Sunamura S, Kikuchi N, Satoh T, Kurosawa R, et al. Small GTP-Binding Protein GDP Dissociation Stimulator Prevents Thoracic Aortic Aneurysm Formation and Rupture by Phenotypic Preservation of Aortic Smooth Muscle Cells. Circulation. 2018; 138: 2413–2433.
[29]
Ohno T, Aoki H, Ohno S, Nishihara M, Furusho A, Hiromatsu S, et al. Cytokine Profile of Human Abdominal Aortic Aneurysm: Involvement of JAK/STAT Pathway. Annals of Vascular Diseases. 2018; 11: 84–90.
[30]
Baxter BT, Matsumura J, Curci JA, McBride R, Larson L, Blackwelder W, et al. Effect of Doxycycline on Aneurysm Growth among Patients with Small Infrarenal Abdominal Aortic Aneurysms. Journal of the American Medical Association. 2020; 323: 2029–2038.
[31]
Zhang D, Liu L, Huang X, Tian J. Tian. Insights Into Coronary Artery Lesions in Kawasaki Disease. Frontiers in Pediatrics. 2020; 8: 493.
[32]
Zeisbrich M, Yanes RE, Zhang H, Watanabe R, Li Y, Brosig L, et al. Hypermetabolic macrophages in rheumatoid arthritis and coronary artery disease due to glycogen synthase kinase 3b inactivation. Annals of the Rheumatic Diseases. 2018; 77: 1053–1062.
[33]
Bucerius J, Dijkgraaf I, Mottaghy FM, Schurgers LJ. Target identification for the diagnosis and intervention of vulnerable atherosclerotic plaques beyond 18 F fluorodeoxyglucose positron emission tomography imaging: promising tracers on the horizon. European Journal of Nuclear Medicine and Molecular Imaging. 2019; 46: 251–265.
[34]
Warden BA, Fazio S, Shapiro MD. The PCSK9 revolution: Current status, controversies, and future directions. Trends in Cardiovascular Medicine. 2020; 30: 179–185.
[35]
Tomiyama H, Koji Y, Yambe M, Motobe K, Shiina K, Gulnisa Z, et al. Elevated C-reactive protein augments increased arterial stiffness in subjects with the metabolic syndrome. Hypertension. 2005; 45: 997–1003.
[36]
AlMahameed ST, Novaro GM, Asher CR, Hougthaling PL, Lago RM, Bhatt DL, et al. Predictive value of high sensitivity C-reactive protein in the diagnosis and outcomes of acute aortic syndromes. Heart Asia. 2010; 2: 136–139.
[37]
Sidloff D, Choke E, Stather P, Bown M, Thompson J, Sayers R. Mortality from thoracic aortic diseases and associations with cardiovascular risk factors. Circulation. 2014; 130: 2287–2294.
[38]
Xie X, Ma X, Zeng S, Tang W, Xiao L, Zhu C, et al. Mechanisms of Berberine for the Treatment of Atherosclerosis Based on Network Pharmacology. Evidence-Based Complementary and Alternative Medicine. 2020; 2020: 3568756.
[39]
Banach M, Patti AM, Giglio RV, Cicero AFG, Atanasov AG, Bajraktari G, et al. The Role of Nutraceuticals in Statin Intolerant Patients. Journal of the American College of Cardiology. 2018; 72: 96–118.
[40]
Cheng F, Wang Y, Li J, Su C, Wu F, Xia W, et al. Berberine improves endothelial function by reducing endothelial microparticles-mediated oxidative stress in humans. International Journal of Cardiology. 2013; 167: 936–942.
[41]
Li G, Qin L, Wang L, Li X, Caulk AW, Zhang J, et al. Inhibition of the mTOR pathway in abdominal aortic aneurysm: implications of smooth muscle cell contractile phenotype, inflammation, and aneurysm expansion. American Journal of Physiology. Heart and Circulatory Physiology. 2017; 312: H1110–H1119.
[42]
Meher AK, Spinosa M, Davis JP, Pope N, Laubach VE, Su G, et al. Novel Role of IL (Interleukin)-1β in Neutrophil Extracellular Trap Formation and Abdominal Aortic Aneurysms. Arteriosclerosis, Thrombosis, and Vascular Biology. 2018; 38: 843–853.
[43]
Batra R, Suh MK, Carson JS, Dale MA, Meisinger TM, Fitzgerald M, et al. IL-1β (Interleukin-1β) and TNF-α (Tumor Necrosis Factor-α) Impact Abdominal Aortic Aneurysm Formation by Differential Effects on Macrophage Polarization. Arteriosclerosis, Thrombosis, and Vascular Biology. 2018; 38: 457–463.
[44]
Liu S, Huang T, Liu R, Cai H, Pan B, Liao M, et al. Spermidine Suppresses Development of Experimental Abdominal Aortic Aneurysms. Journal of the American Heart Association. 2020; 9: e014757.
[45]
Malecki C, Hambly BD, Jeremy RW, Robertson EN. The Role of Inflammation and Myeloperoxidase- Related Oxidative Stress in the Pathogenesis of Genetically Triggered Thoracic Aortic Aneurysms. International Journal of Molecular Sciences. 2020; 21: 7678.
[46]
Jung J, Razavian M, Kim H, Ye Y, Golestani R, Toczek J, et al. Matrix metalloproteinase inhibitor, doxycycline and progression of calcific aortic valve disease in hyperlipidemic mice. Scientific Reports. 2016; 6: 32659.
[47]
Aikawa M, Rabkin E, Sugiyama S, Voglic SJ, Fukumoto Y, Furukawa Y, et al. An HMG-CoA reductase inhibitor, cerivastatin, suppresses growth of macrophages expressing matrix metalloproteinases and tissue factor in vivo and in vitro. Circulation. 2001; 103: 276–283.
[48]
Robbins CS, Byrne JS. Interleukin-3 is required for thoracic aneurysm and dissection in a mouse model. Clinical Science. 2018; 132: 1253–1256.
[49]
Liu C, Zhang C, Jia L, Chen B, Liu L, Sun J, et al. Interleukin-3 stimulates matrix metalloproteinase 12 production from macrophages promoting thoracic aortic aneurysm/dissection. Clinical Science. 2018; 132: 655–668.
[50]
Wei LH, Yang Y, Wu G, Ignarro LJ. IL-4 and IL-13 upregulate ornithine decarboxylase expression by PI3K and MAP kinase pathways in vascular smooth muscle cells. American Journal of Physiology. Cell Physiology. 2008; 294: C1198–C1205.
[51]
Gawinecka J, Schönrath F, von Eckardstein A. Acute aortic dissection: pathogenesis, risk factors and diagnosis. Swiss Medical Weekly. 2017; 147: w14489.
[52]
Chistiakov DA, Bobryshev YV, Orekhov AN. Macrophage-mediated cholesterol handling in atherosclerosis. Journal of Cellular and Molecular Medicine. 2016; 20: 17–28.
[53]
Fernández-Friera L, Fuster V, López-Melgar B, Oliva B, García-Ruiz JM, Mendiguren J, et al. Normal LDL-Cholesterol Levels are Associated with Subclinical Atherosclerosis in the Absence of Risk Factors. Journal of the American College of Cardiology. 2017; 70: 2979–2991.
[54]
Magni P. Bicuspid aortic valve, atherosclerosis and changes of lipid metabolism: are there pathological molecular links? Journal of Molecular and Cellular Cardiology. 2019; 129: 231–235.
[55]
Guo Y, Yan B, Gui Y, Tang Z, Tai S, Zhou S, et al. Physiology and role of PCSK9 in vascular disease: Potential impact of localized PCSK9 in vascular wall. Journal of Cellular Physiology. 2021; 236: 2333–2351.
[56]
Soto ME, Guarner-Lans V, Herrera-Morales KY, Pérez-Torres I. Participation of Arachidonic Acid Metabolism in the Aortic Aneurysm Formation in Patients with Marfan Syndrome. Frontiers in Physiology. 2018; 9: 77.
[57]
Mateuszuk Ł, Campagna R, Kutryb-Zając B, Kuś K, Słominska EM, Smolenski RT, et al. Reversal of endothelial dysfunction by nicotinamide mononucleotide via extracellular conversion to nicotinamide riboside. Biochemical Pharmacology. 2020; 178: 114019.
[58]
Bai T, Li M, Liu Y, Qiao Z, Wang Z. Inhibition of ferroptosis alleviates atherosclerosis through attenuating lipid peroxidation and endothelial dysfunction in mouse aortic endothelial cell. Free Radical Biology and Medicine. 2020; 160: 92–102.
[59]
Sato H, Kato R, Isogai Y, Saka G, Ohtsuki M, Taketomi Y, et al. Analyses of group III secreted phospholipase a2 transgenic mice reveal potential participation of this enzyme in plasma lipoprotein modification, macrophage foam cell formation, and atherosclerosis. The Journal of Biological Chemistry. 2008; 283: 33483–33497.
[60]
Butt HZ, Sylvius N, Salem MK, Wild JB, Dattani N, Sayers RD, et al. Microarray-based Gene Expression Profiling of Abdominal Aortic Aneurysm. European Journal of Vascular and Endovascular Surgery. 2016; 52: 47–55.
[61]
Moubarak M, Jabbour H, Smayra V, Chouery E, Saliba Y, Jebara V, et al. Cardiorenal syndrome in hypertensive rats: microalbuminuria, inflammation and ventricular hypertrophy. Physiological Research. 2012; 61: 13–24.
[62]
Nordskog BK, Blixt AD, Zieske AW, Hellmann GM. MMP-1 polymorphic expression in aortic endothelial cells: possible role in lesion development in smokers and nonsmokers. Cardiovascular Toxicology. 2004; 4: 75–84.
[63]
Bowler MA, Bersi MR, Ryzhova LM, Jerrell RJ, Parekh A, Merryman WD. Cadherin-11 as a regulator of valve myofibroblast mechanobiology. American Journal of Physiology-Heart and Circulatory Physiology. 2018; 315: H1614–H1626.
[64]
Narang N, Lang RM, Liarski VM, Jeevanandam V, Hofmann Bowman MA. Aortic Valve Replacement for Moderate Aortic Stenosis with Severe Calcification and Left Ventricualr Dysfunction-a Case Report and Review of the Literature. Frontiers in Cardiovascular Medicine. 2017; 4: 14.
[65]
Gendron N, Rosa M, Blandinieres A, Sottejeau Y, Rossi E, Van Belle E, et al. Human Aortic Valve Interstitial Cells Display Proangiogenic Properties During Calcific Aortic Valve Disease. Arteriosclerosis, Thrombosis, and Vascular Biology. 2021; 41: 415– 429.
[66]
Duan B, Xu C, Das S, Chen JM, Butcher JT. Spatial Regulation of Valve Interstitial Cell Phenotypes within Three-Dimensional Micropatterned Hydrogels. ACS Biomaterials Science & Engineering. 2019; 5: 1416–1425.
[67]
Wu B, Wang Y, Xiao F, Butcher JT, Yutzey KE, Zhou B. Developmental Mechanisms of Aortic Valve Malformation and Disease. Annual Review of Physiology. 2017; 79: 21–41.
[68]
Vidavsky N, Kunitake JAMR, Estroff LA. Multiple Pathways for Pathological Calcification in the Human Body. Advanced Healthcare Materials. 2021; 10: e2001271.
[69]
Albanese I, Yu B, Al-Kindi H, Barratt B, Ott L, Al-Refai M, et al. Role of Noncanonical Wnt Signaling Pathway in Human Aortic Valve Calcification. Arteriosclerosis, Thrombosis, and Vascular Biology. 2017; 37: 543–552.
[70]
Zheng D, Zang Y, Xu H, Wang Y, Cao X, Wang T, et al. MicroRNA-214 promotes the calcification of human aortic valve interstitial cells through the acceleration of inflammatory reactions with activated MyD88/NF-κB signaling. Clinical Research in Cardiology. 2019; 108: 691–702.
[71]
Balogh E, Chowdhury A, Ababneh H, Csiki DM, Tóth A, Jeney V. Heme-Mediated Activation of the Nrf2/HO-1 Axis Attenuates Calcification of Valve Interstitial Cells. Biomedicines. 2021; 9: 427.
[72]
Laguna-Fernandez A, Carracedo M, Jeanson G, Nagy E, Eriksson P, Caligiuri G, et al. Iron alters valvular interstitial cell function and is associated with calcification in aortic stenosis. European Heart Journal. 2016; 37: 3532–3535.
[73]
Joseph J, Naqvi SY, Giri J, Goldberg S. Aortic Stenosis: Pathophysiology, Diagnosis, and Therapy. The American Journal of Medicine. 2017; 130: 253–263.
[74]
Lindman BR, Clavel M, Mathieu P, Iung B, Lancellotti P, Otto CM, et al. Calcific aortic stenosis. Nature Reviews. Disease Primers. 2016; 2: 16006.
[75]
Alushi B, Curini L, Christopher MR, Grubitzch H, Landmesser U, Amedei A, et al. Lauten, Calcific Aortic Valve Disease-Natural History and Future Therapeutic Strategies. Frontiers in Pharmacology. 2020; 11: 685.
[76]
Huang Y, Zhou X, Liu M, Zhou T, Shi J, Dong N, et al. The natural compound andrographolide inhibits human aortic valve interstitial cell calcification via the NF-kappa B/Akt/ERK pathway. Biomedicine and Pharmacotherapy. 2020; 125: 109985.
[77]
Zhong S, Li L, Shen X, Li Q, Xu W, Wang X, et al. An update on lipid oxidation and inflammation in cardiovascular diseases. Free Radical Biology and Medicine. 2019; 144: 266–278.
[78]
Zhang Z, Zou G, Chen X, Lu W, Liu J, Zhai S, et al. Knockdown of lncRNA PVT1 Inhibits Vascular Smooth Muscle Cell Apoptosis and Extracellular Matrix Disruption in a Murine Abdominal Aortic Aneurysm Model. Molecules and Cells. 2019; 42: 218–227.
[79]
Chen D, Weng L, Chen C, Zheng J, Wu T, Zeng S, et al. Inflammation and dysfunction in human aortic endothelial cells associated with poly-l-lactic acid degradation in vitro are alleviated by curcumin. Journal of Biomedical Materials Research - Part A. 2019; 107: 2756–2763.
[80]
Rahman K, Vengrenyuk Y, Ramsey SA, Vila NR, Girgis NM, Liu J, et al. Inflammatory Ly6Chi monocytes and their conversion to M2 macrophages drive atherosclerosis regression. the Journal of Clinical Investigation. 2017; 127: 2904–2915.
[81]
Mosch J, Gleissner CA, Body S, Aikawa E. Histopathological assessment of calcification and inflammation of calcific aortic valves from patients with and without diabetes mellitus. Histology and Histopathology. 2017; 32: 293–306.
[82]
Xu Y, Si Y, Takekawa J, Liu Q, Prins HHT, Yin S, et al. A network approach to prioritize conservation efforts for migratory birds. Conservation Biology. 2020; 34: 416–426.
[83]
Cochain C, Vafadarnejad E, Arampatzi P, Pelisek J, Winkels H, Ley K, et al. Single-Cell RNA-Seq Reveals the Transcriptional Landscape and Heterogeneity of Aortic Macrophages in Murine Atherosclerosis. Circulation Research. 2018; 122: 1661–1674.
[84]
Chen Y, Yang M, Huang W, Chen W, Zhao Y, Schulte ML, et al. Mitochondrial Metabolic Reprogramming by CD36 Signaling Drives Macrophage Inflammatory Responses. Circulation Research. 2019; 125: 1087–1102.
[85]
Purroy A, Roncal C, Orbe J, Meilhac O, Belzunce M, Zalba G, et al. Matrix metalloproteinase-10 deficiency delays atherosclerosis progression and plaque calcification. Atherosclerosis. 2018; 278: 124–134.
[86]
Sun Y, Zhong L, He X, Wang S, Lai Y, Wu W, et al. LncRNA H19 promotes vascular inflammation and abdominal aortic aneurysm formation by functioning as a competing endogenous RNA. Journal of Molecular and Cellular Cardiology. 2019; 131: 66–81.
[87]
Loperena R, Van Beusecum JP, Itani HA, Engel N, Laroumanie F, Xiao L, et al. Hypertension and increased endothelial mechanical stretch promote monocyte differentiation and activation: roles of STAT3, interleukin 6 and hydrogen peroxide. Cardiovascular Research. 2018; 114: 1547–1563.
[88]
Sprague AH, Khalil RA. Inflammatory cytokines in vascular dysfunction and vascular disease. Biochemical Pharmacology. 2009; 78: 539–552.
[89]
Agharazii M, St-Louis R, Gautier-Bastien A, Ung R, Mokas S, Larivière R, et al. Inflammatory cytokines and reactive oxygen species as mediators of chronic kidney disease-related vascular calcification. American Journal of Hypertension. 2015; 28: 746–755.
[90]
Sun HJ, Ren XS, Xiong XQ, Chen YZ, Zhao MX, Wang JJ, et al. NLRP3 inflammasome activation contributes to VSMC phenotypic transformation and proliferation in hypertension. Cell Death and Disease. 2017; 8: e3074.
[91]
Raffort J, Lareyre F, Clément M, Hassen-Khodja R, Chinetti G, Mallat Z. Monocytes and macrophages in abdominal aortic aneurysm. Nature Reviews. Cardiology. 2017; 14: 457–471.
[92]
Kasashima S, Kawashima A, Kasashima F, Endo M, Matsumoto Y, Kawakami K. Inflammatory features, including symptoms, increased serum interleukin-6, and C-reactive protein, in IgG4-related vascular diseases. Heart and Vessels. 2018; 33: 1471–1481.
[93]
Abplanalp WT, Mas-Peiro S, Cremer S, John D, Dimmeler S, Zeiher AM. Association of Clonal Hematopoiesis of Indeterminate Potential with Inflammatory Gene Expression in Patients with Severe Degenerative Aortic Valve Stenosis or Chronic Postischemic Heart Failure. JAMA Cardiology. 2020; 5: 1170–1175.
[94]
Liu YY, Luo J, Cai R, Zhang J, Xu Q, Tian Y, et al. Macrophage Depletion Improves Endothelial Insulin Resistance and Protects against Cardiovascular Injury in Salt-Sensitive Hypertension. BioMed Research International. 2020; 2020: 5073762.
[95]
Ramírez CM, Zhang X, Bandyopadhyay C, Rotllan N, Sugiyama MG, Aryal B, et al. Caveolin-1 Regulates Atherogenesis by Attenuating Low-Density Lipoprotein Transcytosis and Vascular Inflammation Independently of Endothelial Nitric Oxide Synthase Activation. Circulation. 2019; 140: 225–239.
[96]
Matilla L, Ibarrola J, Arrieta V, Garcia-Peña A, Martinez-Martinez E, Sádaba R, et al. Soluble ST2 promotes oxidative stress and inflammation in cardiac fibroblasts: an in vitro and in vivo study in aortic stenosis. Clinical Science. 2019; 133: 1537–1548.
[97]
Sverdlov AL, Ngo DT, Chapman MJ, Ali OA, Chirkov YY, Horowitz JD. Pathogenesis of aortic stenosis: not just a matter of wear and tear. American Journal of Cardiovascular Disease. 2011; 2: 185–199.
[98]
Sun L, Wang C, Yuan Y, Guo Z, He Y, Ma W, et al. Downregulation of HDAC1 suppresses media degeneration by inhibiting the migration and phenotypic switch of aortic vascular smooth muscle cells in aortic dissection. Journal of Cellular Physiology. 2020; 235: 8747–8756.
[99]
Wen D, Zhou X, Li J, Hui R. Biomarkers in aortic dissection. Clinica Chimica Acta. 2011; 412: 688–695.
[100]
Choke E, Cockerill GW, Laing K, Dawson J, Wilson WRW, Loftus IM, et al. Whole genome-expression profiling reveals a role for immune and inflammatory response in abdominal aortic aneurysm rupture. European Journal of Vascular and Endovascular Surgery. 2009; 37: 305–310.
[101]
Chen Y, Xiong N, Wang X, Wu S, Hong L, Huang X, et al. Efficiency of atorvastatin on in-hospital mortality of patients with acute aortic dissection (AAD): study protocol for a randomized, open-label, superiority clinical trial. Trials. 2021; 22: 281.
[102]
Shimizu K, Shichiri M, Libby P, Lee RT, Mitchell RN. Th2-predominant inflammation and blockade of IFN-gamma signaling induce aneurysms in allografted aortas. The Journal of Clinical Investigation. 2004; 114: 300–308.
[103]
Shimizu K, Sugiyama S, Aikawa M, Fukumoto Y, Rabkin E, Libby P, et al. Host bone-marrow cells are a source of donor intimal smooth- muscle-like cells in murine aortic transplant arteriopathy. Nature Medicine. 2001; 7: 738–741.
[104]
Seldin MM, Meng Y, Qi H, Zhu W, Wang Z, Hazen SL, et al. Trimethylamine N-Oxide Promotes Vascular Inflammation Through Signaling of Mitogen-Activated Protein Kinase and Nuclear Factor-κB. Journal of the American Heart Association. 2016; 5: e002767.
[105]
Sun X, He S, Wara AKM, Icli B, Shvartz E, Tesmenitsky Y, et al. Systemic delivery of microRNA-181b inhibits nuclear factor-κB activation, vascular inflammation, and atherosclerosis in apolipoprotein E-deficient mice. Circulation Research. 2014; 114: 32–40.
[106]
Li SN, Wang X, Zeng QT, Feng YB, Cheng X, Mao XB, et al. Metformin inhibits nuclear factor kappaB activation and decreases serum high-sensitivity C-reactive protein level in experimental atherogenesis of rabbits. Heart and Vessels. 2009; 24: 446–453.
[107]
Feng J, Li S, Chen H. Tanshinone IIA inhibits myocardial remodeling induced by pressure overload via suppressing oxidative stress and inflammation: Possible role of silent information regulator 1. European Journal of Pharmacology. 2016; 791: 632–639.
[108]
Xu K, Zhou T, Huang Y, Chi Q, Shi J, Zhu P, et al. Anthraquinone Emodin Inhibits Tumor Necrosis Factor Alpha-Induced Calcification of Human Aortic Valve Interstitial Cells via the NF-κB Pathway. Frontiers in Pharmacology. 2018; 9: 1328.
[109]
Liu H, Luo Z, Liu L, Yang X, Zhuang Y, Tu G, et al. Inflammatory biomarkers to predict adverse outcomes in postoperative patients with acute type A aortic dissection. Scandinavian Cardiovascular Journal. 2020; 54: 37–46.
[110]
del Porto F, Proietta M, Tritapepe L, Miraldi F, Koverech A, Cardelli P, et al. Inflammation and immune response in acute aortic dissection. Annals of Medicine. 2010; 42: 622–629.
[111]
Ju Xiaoxi,Ijaz Talha,Sun Hong, et al. Interleukin-6-signal transducer and activator of transcription-3 signaling mediates aortic dissections induced by angiotensin II via the T-helper lymphocyte 17-interleukin 17 axis in C57BL/6 mice. Arteriosclerosis Thrombosis and Vascular Biology, 2013, 33: 1612-21.
[112]
Tieu Brian C,Lee Chang,Sun Hong, et al. An adventitial IL-6/MCP1 amplification loop accelerates macrophage-mediated vascular inflammation leading to aortic dissection in mice. Journal of Clinical Investigation, 2009, 119: 3637-51.
[113]
Wen D, Zhou XL, Li JJ, Luo F, Zhang L, Gao LG, et al. Plasma concentrations of interleukin-6, C-reactive protein, tumor necrosis factor-α and matrix metalloproteinase-9 in aortic dissection. Clinica Chimica Acta. 2012; 143: 198–202.
[114]
Sbarouni E, Georgiadou P, Marathias A, Geroulanos S, Kremastinos DT. D-dimer and BNP levels in acute aortic dissection. International Journal of Cardiology. 2007; 122: 170–172.
[115]
Sakakura K, Kubo N, Ako J, Wada H, Fujiwara N, Funayama H, et al. Peak C-reactive protein level predicts long-term outcomes in type B acute aortic dissection. Hypertension. 2010; 55: 422–429.
[116]
Wen D, Du X, Dong J, Zhou X, Ma C. Value of D-dimer and C reactive protein in predicting inhospital death in acute aortic dissection. Heart. 2013; 99: 1192–1197.
[117]
Kurihara T, Shimizu-Hirota R, Shimoda M, Adachi T, Shimizu H, Weiss SJ, et al. Neutrophil-derived matrix metalloproteinase 9 triggers acute aortic dissection. Circulation. 2012; 126: 3070–3080.
[118]
Guo LL, Wu MT, Zhang LW, Chu YX, Tian P, Jing ZP, et al. Blocking Interleukin-1 Beta Reduces the Evolution of Thoracic Aortic Dissection in a Rodent Model. European Journal of Vascular and Endovascular Surgery. 2020; 60: 916–924.
Publisher’s Note: IMR Press stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Share
Back to top